on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Spire Healthcare
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure related to its interests in Spire Healthcare Group plc. According to the latest filing, dated February 23, 2026, Vanguard controls 3.60% of Spire's securities, totaling 14,518,818 ordinary shares. This disclosure aligns with Rule 8.3 of the Takeover Code, which requires transparency for entities holding 1% or more of the relevant securities.
Additionally, the document notes that Vanguard has recently acquired 8,992 shares at £1.99 each. There are no cash-settled or stock-settled derivative positions mentioned. Furthermore, there are no disclosed indemnity or option agreements or arrangements related to Spire’s securities.
The notification reaffirms Vanguard's stake and signals its investment interest in the healthcare sector, as represented by Spire Healthcare Group. No supplemental Form 8 is attached to this disclosure.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news